BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17143564)

  • 1. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
    Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
    Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting.
    Paiva MS; Serrano CV; Nicolau JC; Jalbut BO; Fernandes JL; De Lemos JA; Blotta MH; De Oliveira RT; De Oliveira IR; De Oliveira Lda A; Ramires JA
    J Interv Cardiol; 2008 Oct; 21(5):403-9. PubMed ID: 18705636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance as a predictor for restenosis after coronary stenting.
    Nishio K; Fukui T; Tsunoda F; Kawamura K; Itoh S; Konno N; Ozawa K; Katagiri T
    Int J Cardiol; 2005 Aug; 103(2):128-34. PubMed ID: 16080969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and prognostic value of inflammatory-sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Koskinas K; Gemitzis K; Hatzimiltiadis S; Efthimiadis G; Paraskevaidis S; Hatzitolios A; Savopoulos C; Parharidis G
    Med Sci Monit; 2009 Apr; 15(4):CR177-84. PubMed ID: 19333202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.
    Inoue T; Kato T; Uchida T; Sakuma M; Nakajima A; Shibazaki M; Imoto Y; Saito M; Hashimoto S; Hikichi Y; Node K
    J Am Coll Cardiol; 2005 Jul; 46(2):239-45. PubMed ID: 16022949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
    Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
    Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
    Moldoveanu E; Mut-Vitcu B; Tanaseanu GR; Marta DS; Manea G; Kosaka T; Vidulescu C; Tanaseanu C
    Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preprocedural C-reactive protein levels predict myocardial necrosis after successful coronary stenting in patients with stable angina.
    Goldberg A; Gruberg L; Roguin A; Petcherski S; Rimer D; Markiewicz W; Beyar R; Aronson D
    Am Heart J; 2006 Jun; 151(6):1265-70. PubMed ID: 16781234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
    Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M
    Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):341-5. PubMed ID: 12112886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis.
    Li JJ; Fang CH; Jiang H; Huang CX; Hui RT; Chen MZ
    Clin Chim Acta; 2004 Dec; 350(1-2):115-21. PubMed ID: 15530467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.